For The 1st time, WHO’s treatment rules incorporate a clear advice for the use of prolonged-performing injectable cabotegravir and rilpivirine (CAB/RPV) instead switching option for antiretroviral therapy (Artwork) for Older people and adolescents who've realized full viral suppression on oral ART and do not have Lively hepatitis B infection. The https://maps.app.goo.gl/SucmaxKzrENyUBfj9